Table 2 Summary of best tumor response according to prior anthracycline exposure
No. of Pts | No. of Responders | Percent of Pts | 95% CI | |
|---|---|---|---|---|
Evaluable patients | 35 | 14 | 40.0% | (23.8%–56.2%) |
Prior anthracycline exposure | ||||
Yes | 22 | 6 | 27.3% | (8.7%–45.9%) |
No | 13 | 8 | 61.5% | (35.1%–88.0%) |